WMGI - Wright Medical Group N.V.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Wright Medical Group N.V.

Prins Bernhardplein 200
Amsterdam 1097 JB
Netherlands
31 20 521 4777
http://www.wright.com

SectorHealthcare
IndustryMedical Devices
Full Time Employees2,894

Key Executives

NameTitlePayExercisedYear Born
Mr. Robert J. PalmisanoPres, CEO & Exec. Director2.24MN/A1945
Mr. Lance A. BerryExec. VP, CFO & COO817.73kN/A1972
Mr. Andrew C. MortonSr. VP & Chief HR Officer973.48kN/A1966
Mr. Kevin D. CordellExec. VP & Chief Global Commercial Officer825.09kN/A1966
Mr. Peter S. CookePres of emerging markets, Australia & Japan2.18M195.78k1965
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries, as well as other ancillary products. The company primarily offers its products to orthopedic, trauma, and podiatric surgeons. It markets and sells its products through direct sales representatives, independent sales agencies, direct sales offices, and distributors. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands.

Corporate Governance

Wright Medical Group N.V.’s ISS Governance QualityScore as of July 29, 2019 is 4. The pillar scores are Audit: 3; Board: 2; Shareholder Rights: 2; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.